Recent Updates
Recently added Catalysts
LLY Positive Sentiment

Lilly Drafts Shaquille O'Neal to Raise Awareness for Moderate-to-Severe Obstructive Sleep Apnea Basketball legend, entrepreneur and entertainer Shaquille O'Neal partners with Lilly to shine a spotlight on moderate-to-severe obstructive sleep...

Key Takeaway: Eli Lilly has partnered with basketball legend Shaquille O'Neal for a nationwide awareness campaign on moderate-to-severe obstructive sleep apnea (OSA). The campaign, titled 'Don't Sleep on OSA,' seeks to educate the public about the symptoms and health impacts of this underdiagnosed condition. O'Neal will share his experiences with OSA to encourage those suffering from related symptoms to seek medical advice. This initiative targets the estimated 24 million adults affected by OSA in the U.S.
Price reaction · baseline $825.45 (2025-10-24 close) · 6 other LLY headline(s) in the window, move may be shared
day 0 close · peak
+0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Partnership with Shaquille O'Neal raises significant awareness.
  • Campaign aims to educate millions about obstructive sleep apnea.
  • O'Neal's personal story adds authenticity and relatability.
  • Encourages proactive communication with healthcare providers.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+45%
120-day peak, hindsight
Typical move
2%
average across 15 past catalysts
Lead asset
Dulaglutide
Phase 3 · Type 2 Diabetes Mellitus

Full Press Release Details

Basketball legend, entrepreneur and entertainer Shaquille O'Neal partners with Lilly to shine a spotlight on moderate-to-severe obstructive sleep apnea (OSA), encouraging Americans to talk to their doctor
Moderate-to-severe obstructive sleep apnea (OSA) is a serious, often underdiagnosed health condition that affects an estimated 24 million adults in the U.S. 1 – many of whom are overweight or living with obesity 2 – yet most cases remain undiagnosed
Shaquille O'Neal joins Lilly's Don't Sleep on OSA initiative, empowering people to recognize symptoms and talk to their healthcare providers
INDIANAPOLIS , Oct. 27, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) today announced a new partnership with NBA Hall of Famer and cultural icon Shaquille O'Neal to launch a nationwide campaign raising awareness about moderate-to-severe obstructive sleep apnea (OSA). The initiative aims to educate the public about the symptoms and potential health impacts of moderate-to-severe OSA, a serious but often overlooked health condition that impacts 24 million people in the U.S., many of whom are overweight or living with obesity.
Shaquille O'Neal is sharing his personal journey with moderate OSA in partnership with Lilly to urge people living with obesity not to ignore the symptoms of moderate-to-severe OSA, including loud snoring, choking and/or gasping for air while sleeping, daytime sleepiness, fatigue or irritability, which often remains undiagnosed. Through a series of digital and media activations that build on Lilly's Don't Sleep on OSA campaign, Shaquille will encourage people to recognize the symptoms of moderate-to-severe OSA and take action by visiting DontSleepOnOSA.com and by talking to their healthcare provider.
"Moderate-to-severe obstructive sleep apnea is more than just snoring – it's a serious condition and it deserves serious attention," O'Neal shared. "For years, I was tired all the time and didn't know why, but getting diagnosed made a real difference. I'm not always one to ask for help, and I know it can be difficult to speak up when something is impacting you. I'm here to say don't ignore moderate-to-severe OSA symptoms – talk to your doctor."
Symptoms and Impacts: Why Addressing Moderate-to-Severe OSA Matters People with moderate-to-severe OSA may not get the necessary oxygen due to an airway that is partially or fully blocked at times during sleep 3 . Those with moderate OSA, like Shaquille, may experience breathing interruptions 15-29 times per hour, while 30 or more interruptions an hour may indicate severe OSA 3 . Risk factors for moderate-to-severe OSA include being of the male sex, obesity, being over the age of 50 and having a family history of OSA 4 5 6 . In addition to breathing disruptions during sleep, moderate-to-severe OSA can also cause daytime sleepiness and reduced concentration.
"Moderate-to-severe obstructive sleep apnea is a serious and often overlooked condition that affects millions of Americans," said Lina Polimeni, Senior Vice President and Chief Marketing Officer, Consumer, at Lilly. "By partnering with Shaquille O'Neal, someone who brings authenticity, relatability and cultural reach, we're aiming to break through the stigma and spark real conversations. This campaign, and the exciting work we're doing at Lilly, is about empowering people to recognize possible symptoms and take action."
Talk to your doctor about OSA if you experience symptoms including loud snoring, choking and/or gasping for air while sleeping, daytime sleepiness, fatigue or irritability.
To learn more about symptoms and risk factors for moderate-to-severe OSA in adults with obesity, as well as tools for speaking to your doctor, visit DontSleepOnOSA.com .
Refer to: JohnMark Conklin; [email protected] ; 828-989-1717 (Media)
Michael Czapar; [email protected] ; 317-617-0983 (Investors)
1 Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med . 2019;7(8):687-698.
2 Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol . 2005;99(4):1592-1599.
3 Gottlieb DJ, Punjabi NM. Diagnosis and management of obstructive sleep apnea: a review. JAMA . 2020;323(14):1389-1400.
4 Chang JL, Goldberg AN, Alt JA, et al. International consensus statement on obstructive sleep apnea. Int Forum Allergy Rhinol. 2023;13(7):1061-1482.
5 Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;144(3):e56-e67.
6 Abbasi A, Gupta SS, Sabharwal N, et al. A comprehensive review of obstructive sleep apnea. Sleep Sci. 2021;14(2):142-154.

Frequently Asked Questions

What is the Don't Sleep on OSA initiative?

The Don't Sleep on OSA initiative aims to raise awareness about moderate-to-severe obstructive sleep apnea (OSA) and encourage individuals to recognize symptoms and consult healthcare providers.

Who is partnering with Lilly to raise OSA awareness?

Shaquille O'Neal, the NBA Hall of Famer, has partnered with Lilly to promote awareness of moderate-to-severe obstructive sleep apnea.

What symptoms indicate moderate-to-severe OSA?

Symptoms of moderate-to-severe OSA include loud snoring, choking or gasping during sleep, daytime sleepiness, fatigue, and irritability.

Why is OSA often underdiagnosed?

OSA is often underdiagnosed because many individuals do not recognize their symptoms or do not seek medical advice.

How can I learn more about OSA?

You can learn more about moderate-to-severe OSA by visiting DontSleepOnOSA.com for information on symptoms and risk factors.

Last updated: Oct 27, 2025